Cardiovascular Systems, Inc.

NasdaqGS:CSII Stock Report

Market Cap: US$844.0m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Cardiovascular Systems Past Earnings Performance

Past criteria checks 0/6

Key information

-54.5%

Earnings growth rate

-52.3%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate2.1%
Return on equity-15.8%
Net Margin-15.8%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

Feb 03
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Oct 12
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates

Aug 03

Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 05
Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

Oct 09
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Sep 18
At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Jun 24
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Jun 03
Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Apr 29
We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Mar 17
Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Feb 10
Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Cardiovascular Systems misses on revenue

Feb 03

Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Dec 11
Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation

Nov 06

Revenue & Expenses Breakdown

How Cardiovascular Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:CSII Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 22240-3817436
30 Sep 22238-3917336
30 Jun 22236-3717137
31 Mar 22245-3317037
31 Dec 21252-2916941
30 Sep 21257-2016942
30 Jun 21259-1316741
31 Mar 21231-2315739
31 Dec 20228-2015736
30 Sep 20233-2416337
30 Jun 20237-2717039
31 Mar 20262-1117941
31 Dec 19264-717940
30 Sep 19256-317337
30 Jun 19248016832
31 Mar 19239216230
31 Dec 18231215829
30 Sep 18224115428
30 Jun 18217214927
31 Mar 18211-114526
31 Dec 17207-314524
30 Sep 17205-214224
30 Jun 17205-214423
31 Mar 17199-714623
31 Dec 16191-2814923
30 Sep 16183-4515724
30 Jun 16177-5616126

Quality Earnings: CSII is currently unprofitable.

Growing Profit Margin: CSII is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CSII is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.

Accelerating Growth: Unable to compare CSII's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CSII is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.5%).


Return on Equity

High ROE: CSII has a negative Return on Equity (-15.82%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.